CIK 0001585364 · Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- Phone
- 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-14 | Bezerra Eduardo Guarita EVP & Chief Financial Officer | Purchase | +5,000 | $29.18 | $146K | 8,428 |
| 2023-11-14 | Lockwood-Taylor Patrick CEO | Purchase | +11,000 | $28.99 | $319K | 11,000 |
| 2023-10-06 | Schmelter Triona EVP & President CSCA | Grant or award · Restricted Stock Units | +1,641 | 1,641 | ||
| 2023-10-06 | Schmelter Triona EVP & President CSCA | Grant or award · Restricted Stock Units | +5,909 | 5,909 | ||
| 2023-10-06 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +738 | $30.46 | $22K | 9,078 |
| 2023-10-06 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −217 | $30.46 | $7K | 8,861 |
| 2023-10-06 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −738 | 0 | ||
| 2023-08-15 | Manzone Albert Director | Option exercise | +5,478 | $38.88 | $213K | 5,478 |
| 2023-08-15 | Manzone Albert Director | Shares withheld for taxes | −2,630 | $38.88 | $102K | 2,848 |
| 2023-08-15 | Manzone Albert Director | Option exercise · Restricted Stock Units | −5,478 | 0 | ||
| 2023-07-10 | Lockwood-Taylor Patrick CEO | Grant or award · Restricted Stock Units | +84,977 | 84,977 | ||
| 2023-07-07 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +920 | $32.63 | $30K | 8,611 |
| 2023-07-07 | Ives Alison EVP & Chief Scientific Officer | Shares withheld for taxes | −271 | $32.63 | $9K | 8,340 |
| 2023-07-07 | Ives Alison EVP & Chief Scientific Officer | Option exercise · Restricted Stock Units | −920 | 1,839 | ||
| 2023-07-07 | HANSON KYLE EVP & General Counsel | Option exercise | +9,732 | $32.63 | $318K | 9,732 |
| 2023-07-07 | HANSON KYLE EVP & General Counsel | Shares withheld for taxes | −2,857 | $32.63 | $93K | 6,875 |
| 2023-07-07 | HANSON KYLE EVP & General Counsel | Option exercise | +2,677 | $32.63 | $87K | 9,552 |
| 2023-07-07 | HANSON KYLE EVP & General Counsel | Shares withheld for taxes | −786 | $32.63 | $26K | 8,766 |
| 2023-07-07 | HANSON KYLE EVP & General Counsel | Option exercise · Restricted Stock Units | −9,732 | 0 | ||
| 2023-07-07 | HANSON KYLE EVP & General Counsel | Option exercise · Restricted Stock Units | −2,677 | 5,352 |
Page 22 of 27 · 524 trades